(Q44852501)

6 December 2017

title

Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction (English)

1 reference

6 December 2017

main subject

myocardial infarction

1 reference

5

D Oakes

1 reference

6 December 2017

N K Kaba

1

1 reference

6 December 2017

C W Francis

2

1 reference

6 December 2017

A J Moss

3

1 reference

6 December 2017

W Zareba

4

1 reference

6 December 2017

K L Knox

6

1 reference

6 December 2017

I D Fernández

7

1 reference

6 December 2017

D L Rainwater

8

1 reference

6 December 2017

THROMBO Investigators

9

1 reference

6 December 2017

language of work or name

1 reference

1 May 2004

1 reference

Journal of Thrombosis and Haemostasis

6 December 2017

published in

1 reference

6 December 2017

volume

2

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

718-725

1 reference

Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Review of lipid-lowering clinical trials in relation to observational epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

von Willebrand factor: a marker of endothelial damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

Epidemiology of insulin resistance and its relation to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

The metabolic syndrome: practical guide to origins and treatment: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

The metabolic syndrome: a practical guide to origins and treatment: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00658.X

10.1111/J.1538-7836.2004.00658.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference